Robert W Postma is of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 29,083 shares of TCRT, which is worth approximately $69,217. The most recent transaction as insider was on Apr 13, 2025, when has been sold 20,804 shares (Common Stock) at a price of $2.92 per share, resulting in proceeds of $60,747. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.1K
97.66% 3M change
97.66% 12M change
Total Value Held $69,217

Robert W Postma Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 13 2025
BUY
Grant, award, or other acquisition
$60,747 $2.92 p/Share
20,804 Added 41.7%
29,083 Common Stock
Jun 22 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 3.12%
1,241,870 Common Stock
Jun 22 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 3.12%
1,241,870 Common Stock
Sep 02 2021
BUY
Open market or private purchase
$35,479 $1.73 p/Share
20,508 Added 1.68%
1,201,870 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 0.21%
1,181,362 Common Stock
RWP

Robert W Postma

Boston, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Track Activities on TCRT